SGHT Q3 2021 Earnings — Sight Sciences, Inc. Revenue & Financial Results | Market Cap Arena

SGHTSight Sciences, Inc.

$205M

Q3 2021 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$13M+51.4% YoY

Gross Profit

$11M84.3% margin

Operating Income

-$14M-107.1% margin

Net Income

-$17M-131.1% margin

EPS (Diluted)

$-0.43

QoQ Revenue Growth

+4.5%

Cash Flow

Operating Cash Flow

-$17M

Free Cash Flow

-$17M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$291M

Total Liabilities

$45M

Stockholders' Equity

$246M

Cash & Equivalents

$271M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$13M	$9M	+51.4%
Gross Profit	$11M	$6M	+83.0%
Operating Income	-$14M	-$7M	-90.8%
Net Income	-$17M	-$8M	-112.0%

Revenue Segments

Surgical Glaucoma

$12M95%

Dry Eye

$655,0005%